Custom Crystal for Pharma Commercialization Agreement

Custom crystal celebrating a development and commercialization agreement involving Click Therapeutics and pharmaceutical firm Boehringer Ingelheim. The agreement centers on a mobile prescription app for use by patients with schizophrenia. (21AKL599)